| Title： | Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors |
| Edition： | Updated |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | Joanna Briggs Institute，JBI |
| Development unit： | Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology, Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association |
| Registration time: | 2023-02-27 |
| Registration number： | PREPARE-2023CN100 |
| Purpose of the guideline: |
